Quantification of brain metabolites in amyotrophic lateral sclerosis by localized proton magnetic resonance spectroscopy.
about
Proton magnetic resonance spectroscopy (1H-MRS) in ALS.Neuroimaging to investigate multisystem involvement and provide biomarkers in amyotrophic lateral sclerosisALS surrogate markers. MRS.Corticospinal tract degeneration and possible pathogenesis in ALS evaluated by MR diffusion tensor imaging.A comparative study of the different N-acetylaspartate measures of the medial temporal lobe in Alzheimer's disease.A multicenter reproducibility study of single-voxel 1H-MRS of the medial temporal lobe.N-acetylaspartate as a marker of neuronal injury in neurodegenerative disease.Comprehensive evaluation of corticospinal tract metabolites in amyotrophic lateral sclerosis using whole-brain 1H MR spectroscopy.Reanalysis of multislice (1)H MRSI in amyotrophic lateral sclerosis.Review neuroimaging in amyotrophic lateral sclerosis.Magnetic resonance spectroscopy of the cervical cord in amyotrophic lateral sclerosis.Amyotrophic lateral sclerosis: objective upper motor neuron markers.Presymptomatic spinal cord neurometabolic findings in SOD1-positive people at risk for familial ALS.Cerebral degeneration predicts survival in amyotrophic lateral sclerosisAdvanced magnetic resonance neuroimaging in bulbar and limb onset early amyotrophic lateral sclerosisEarly detection and longitudinal changes in amyotrophic lateral sclerosis by (1)H MRSI.Reduced NAA in motor and non-motor brain regions in amyotrophic lateral sclerosis: a cross-sectional and longitudinal study.Biomarkers in amyotrophic lateral sclerosis: facts and future horizons.The present and the future of neuroimaging in amyotrophic lateral sclerosis.Amyotrophic Lateral Sclerosis and Metabolomics: Clinical Implication and Therapeutic Approach.Further development of biomarkers in amyotrophic lateral sclerosis.EFNS guidelines on the use of neuroimaging in the management of motor neuron diseases.Proton magnetic resonance spectroscopy in patients with early stages of amyotrophic lateral sclerosis.Structural and metabolic changes in the brain of patients with upper motor neuron disorders: a multiparametric MRI study.MR spectroscopy findings in early stages of motor neuron disease.A prospective, randomized, placebo-controlled evaluation of corticoneuronal response to intrathecal BDNF therapy in ALS using magnetic resonance spectroscopy: feasibility and results.A prospective pilot study measuring muscle volumetric change in amyotrophic lateral sclerosis.Combined structural and neurochemical evaluation of the corticospinal tract in amyotrophic lateral sclerosis.The size distribution of neurons in the motor cortex in amyotrophic lateral sclerosis.Brain metabolites in definite amyotrophic lateral sclerosis. A longitudinal proton magnetic resonance spectroscopy study.Ultra-High Field Proton MR Spectroscopy in Early-Stage Amyotrophic Lateral Sclerosis.In-vivo evaluation of neuronal and glial changes in amyotrophic lateral sclerosis with diffusion tensor spectroscopyNeuroimaging in amyotrophic lateral sclerosisNeuroimaging in the Management of Motor Neuron DiseasesAmyotrophic Lateral Sclerosis and Frontotemporal DegenerationNon-invasive assessment of disease progression and neuroprotective effects of dietary coconut oil supplementation in the ALS SOD1 mouse model: A H-magnetic resonance spectroscopic studyImaging Biomarkers for the Diagnosis and Prognosis of Neurodegenerative Diseases. The Example of Amyotrophic Lateral Sclerosis
P2860
Q30656819-4C2E6272-CD35-4437-9B59-67E33DFA1203Q30832443-4BBAD783-80FF-454D-B497-046B25D5FE12Q30974180-B20BFEA0-3CE7-4F61-8BCF-9DDAD921093DQ30974187-6F428BD1-6CDE-416C-B11C-3B2043C7B9FAQ30994832-61CA8C31-CD74-4A71-80FD-FCBBD43A2FD0Q31029801-901C87CF-3D3D-4048-91FB-3839C82FB0C6Q31046921-A6A28134-EAE5-4D9C-801A-1BA6B004C96FQ31060094-D044886B-EB9E-4401-B861-487037DD533FQ32163064-BAE2C8AF-1801-4552-8465-36618BDE3E9FQ33755985-C9E896B0-E506-46BA-BE73-78D312C6B0A1Q33766375-F0A58A80-D5A6-4FF0-9C62-09A8185C849AQ34566679-8EB91E5C-DFD4-4A3E-BEBC-0A8F11759D86Q35240090-6BD43B7E-D45B-4944-A75C-29D0E8CC86B9Q36141891-45650A16-6722-4A83-AB2F-1D490A139D9DQ36570542-F9C24A60-F9BE-4BC0-8E54-0B8CC5F5CB8AQ37322633-E687BF1B-0165-41C4-AC54-6BF636B70402Q37348418-864DB077-353B-4FA4-B407-369FEC82E15EQ37523903-DEEA9A21-12AA-4979-9A27-0CFC5DD2D740Q37723166-57AF2D20-35FE-4E4D-90BA-3590C97CDFE8Q38575783-9C8FC6BC-8985-47A5-AF62-0BFC1F3F054BQ38856405-23CC2120-C369-4667-8B13-5DA7C49362D7Q41860558-37F56080-1EA5-422D-A15F-69007247CFB6Q43108890-82B0F1D9-472A-4199-96EC-83B7D5B8EB33Q43239622-1967E7AA-7E05-4BC0-B0DA-D773E56E2912Q43858889-194B910E-A1C5-458D-8A6E-C2B0DAA31F66Q44440114-386FBC0C-B82F-48C8-8BBE-0323E249A60AQ44943147-F558E6CC-393C-45AB-96CF-62EB496FA367Q46109454-520A2BFC-6642-45A6-979D-1A76DA16831CQ47367329-03B51493-AF01-43F7-81D8-1270BEF4A96DQ48204825-13A927CE-19E4-4DA0-A238-E6E414C52DC4Q48337962-F53F0174-6F45-4DC0-B761-C933A1E11162Q57484661-B1A9FFA0-B75D-4E68-B937-AAA52345A93AQ57498892-AEBEE36F-D793-443C-B5D9-E37082F8A16EQ57498941-981D8A9F-189B-4558-84AE-F685794A269DQ58125262-8C5EBC97-F49E-464C-BD87-C85CD9D504DBQ58126926-08097E14-34B6-4B13-B1FB-65EAD0ADDDA0Q58556498-9EC61940-24BF-4443-91F6-5D9D959F6F74
P2860
Quantification of brain metabolites in amyotrophic lateral sclerosis by localized proton magnetic resonance spectroscopy.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Quantification of brain metabo ...... gnetic resonance spectroscopy.
@en
type
label
Quantification of brain metabo ...... gnetic resonance spectroscopy.
@en
prefLabel
Quantification of brain metabo ...... gnetic resonance spectroscopy.
@en
P2093
P356
P1433
P1476
Quantification of brain metabo ...... gnetic resonance spectroscopy.
@en
P2093
P304
P356
10.1212/WNL.48.4.878
P407
P577
1997-04-01T00:00:00Z